Tadanerfi 20 mg 4 orodispersible films

Tadanerfi

Compound:

Each oral dissolvable film contains:

Tadalafil 20 mg

Auxiliary components:

Polyvinyl alcohol, propylene glycol, hydroxypropyl methylcellulose, starch, glycerol, sucrose, menthol, orange oil, simethicone.

Properties:

Tadalafil is a reversible selective inhibitor of specific phosphodiesterase type 5 (PDE5) cyclic guanosine monophosphate (cGMP). When sexual arousal causes local release of nitric oxide, inhibition of PDE5 by tadalafil leads to an increase in the concentration of cGMP in the cavernous body of the penis. The consequence of this is the relaxation of the smooth muscles of the arteries and the flow of blood to the tissues of the penis, which causes an erection. Tadalafil has no effect in the absence of sexual arousal.

Indications:

Erection disorders. Erectile dysfunction.

Dosage and administration:

The film is intended for resorption in the oral cavity. Pre-stick on the tongue.

Middle-aged men are recommended to take a dose of 20 mg at least 20 minutes before the expected sexual activity, regardless of the meal. Patients may attempt intercourse at any time within 36 hours after ingestion in order to establish an optimal response time to tadalafil. The maximum frequency of admission is 1 time / day.

Contraindications:

– the use of drugs containing any organic nitrates;

– the presence of contraindications to sexual activity in patients with diseases of the cardiovascular system;

– loss of vision due to non-arterial anterior ischemic optic neuropathy (regardless of the connection with the intake of PDE5 inhibitors);

– simultaneous use with doxazosin, other PDE5 inhibitors, other treatment options for erectile dysfunction, with guanylate cyclase stimulants such as riociguat;

– chronic renal failure (CC less than 30 ml / min);

– age up to 18 years;

– hypersensitivity to tadalafil or to any substance that is part of the drug.

Precautionary measures:

Diagnosis of erectile dysfunction should include identification of a potential underlying cause, appropriate medical evaluation, and determination of treatment tactics.

Sexual activity has a potential risk for patients with cardiovascular disease. Therefore, the treatment of erectile dysfunction, incl. Tadanerfi should not be used in men with heart conditions for which sexual activity is not recommended.

Side effects:

From the nervous system: often – headache; infrequently – dizziness.

From the side of the vessels: often – “tides” of blood to the face; infrequently – a decrease in blood pressure, an increase in blood pressure.

From the respiratory system: often – nasal congestion.

From the digestive system: often – dyspepsia.

From the musculoskeletal system: often – back pain, myalgia, pain in the extremities.

Storage method:

Store at a temperature not exceeding 30 degrees.

Package:

Cardboard box contains 4 dissolvable films in the oral cavity, paper instructions.